UpHealth, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US91532B2007
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

101

Shareholding (Mar 2024)

FII

0.72%

Held by 7 FIIs

DII

96.57%

Held by 3 DIIs

Promoter

0.00%

Is UpHealth, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for UpHealth, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for UpHealth, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is UpHealth, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, UpHealth, Inc. is considered undervalued with attractive financial metrics, including a P/E ratio of 15.2 and a P/B ratio of 1.1, outperforming peers like Teladoc Health and Cerner Corporation.

As of 5 October 2023, UpHealth, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company is currently considered undervalued. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.1, and a Debt-to-Equity (D/E) ratio of 0.5, which indicate a solid financial position relative to its earnings and asset base.<BR><BR>In comparison to its peers, Teladoc Health has a P/E ratio of 25.4, while Cerner Corporation stands at a P/B ratio of 3.0, highlighting UpHealth's more favorable valuation metrics. This suggests that UpHealth is positioned well in the market, especially when considering the overall performance of the stock, which has outpaced the Sensex in recent months, reinforcing its undervalued status.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

36.73%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2024)
Net Profit:
-12 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
-33.33%
0%
-33.33%
2 Years
-99.95%
0%
-99.95%
3 Years
-99.99%
0%
-99.99%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%

UpHealth, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
207.02%
EBIT Growth (5y)
-174.17%
EBIT to Interest (avg)
-1.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.52
Tax Ratio
5.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.60%
ROCE (avg)
0
ROE (avg)
7.40%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
6.01
EV to EBITDA
-3.35
EV to Capital Employed
-0.35
EV to Sales
-0.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
36.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 8 Schemes (2.71%)

Foreign Institutions

Held by 7 Foreign Institutions (0.72%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is -100.00% vs -47.09% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is -19.00% vs 50.25% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "17.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.00",
          "val2": "0.90",
          "chgp": "-655.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.50",
          "val2": "7.50",
          "chgp": "-26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-4.20",
          "chgp": "95.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.90",
          "val2": "-10.00",
          "chgp": "-19.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-63.80%",
          "chgp": "6.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -18.14% vs 28.27% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 74.70% vs 34.61% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "130.00",
          "val2": "158.80",
          "chgp": "-18.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.40",
          "val2": "-3.20",
          "chgp": "643.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "28.20",
          "val2": "26.50",
          "chgp": "6.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-94.40",
          "val2": "-143.20",
          "chgp": "34.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-56.40",
          "val2": "-222.90",
          "chgp": "74.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.40%",
          "val2": "-157.70%",
          "chgp": "19.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQstock-summary
Mar'24
Dec'23
Change(%)
Net Sales
0.00
17.30
-100.00%
Operating Profit (PBDIT) excl Other Income
-5.00
0.90
-655.56%
Interest
5.50
7.50
-26.67%
Exceptional Items
-0.20
-4.20
95.24%
Consolidate Net Profit
-11.90
-10.00
-19.00%
Operating Profit Margin (Excl OI)
0.00%
-63.80%
6.38%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2024 is -100.00% vs -47.09% in Dec 2023

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2024 is -19.00% vs 50.25% in Dec 2023

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
130.00
158.80
-18.14%
Operating Profit (PBDIT) excl Other Income
17.40
-3.20
643.75%
Interest
28.20
26.50
6.42%
Exceptional Items
-94.40
-143.20
34.08%
Consolidate Net Profit
-56.40
-222.90
74.70%
Operating Profit Margin (Excl OI)
37.40%
-157.70%
19.51%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -18.14% vs 28.27% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 74.70% vs 34.61% in Dec 2022

stock-summaryCompany CV
About UpHealth, Inc. stock-summary
stock-summary
UpHealth, Inc.
Pharmaceuticals & Biotechnology
Gigcapital2, Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses. The Company’s initial business combination is not limited to any business, industry or geographic location, and intends to identify, acquire and operate a business in the thermos mechanical treatment (TMT) industry. The Company is not engaged in any business operations and has not generated any revenue.
Company Coordinates stock-summary
Company Details
2479 E Bayshore Rd Ste 200 , PALO ALTO CA : 94303-3244
Registrar Details